JP2022536581A5 - - Google Patents

Info

Publication number
JP2022536581A5
JP2022536581A5 JP2021561910A JP2021561910A JP2022536581A5 JP 2022536581 A5 JP2022536581 A5 JP 2022536581A5 JP 2021561910 A JP2021561910 A JP 2021561910A JP 2021561910 A JP2021561910 A JP 2021561910A JP 2022536581 A5 JP2022536581 A5 JP 2022536581A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
polypeptides
tmmp
terminus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021561910A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536581A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037919 external-priority patent/WO2020257191A1/en
Publication of JP2022536581A publication Critical patent/JP2022536581A/ja
Publication of JP2022536581A5 publication Critical patent/JP2022536581A5/ja
Pending legal-status Critical Current

Links

JP2021561910A 2019-06-19 2020-06-16 多量体ｔ細胞調節性ポリペプチド及びその使用方法 Pending JP2022536581A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962863754P 2019-06-19 2019-06-19
US62/863,754 2019-06-19
PCT/US2020/037919 WO2020257191A1 (en) 2019-06-19 2020-06-16 Multimeric t-cell modulatory polypeptides and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2022536581A JP2022536581A (ja) 2022-08-18
JP2022536581A5 true JP2022536581A5 (enExample) 2023-06-16

Family

ID=74040105

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021561910A Pending JP2022536581A (ja) 2019-06-19 2020-06-16 多量体ｔ細胞調節性ポリペプチド及びその使用方法

Country Status (4)

Country Link
US (1) US20220017597A1 (enExample)
EP (1) EP3986448A4 (enExample)
JP (1) JP2022536581A (enExample)
WO (1) WO2020257191A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201808552XA (en) * 2016-05-18 2018-10-30 Cue Biopharma Inc T-cell modulatory multimeric polypeptides and methods of use thereof
CN110325205B (zh) 2016-12-22 2023-08-15 库尔生物制药有限公司 T细胞调节性多聚体多肽及其使用方法
US11851471B2 (en) 2017-01-09 2023-12-26 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
KR20240005989A (ko) 2017-03-15 2024-01-12 큐 바이오파마, 인크. 면역 반응을 조절하는 방법
WO2019051127A1 (en) 2017-09-07 2019-03-14 Cue Biopharma, Inc. MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF
WO2019139896A1 (en) 2018-01-09 2019-07-18 Cue Biopharma, Inc. Multimeric t-cell modulatory polypeptides and methods of use thereof
EP3897746A4 (en) * 2018-12-19 2022-10-26 Cue Biopharma, Inc. MULTIMERIC T LYMPHOCYTE MODULATING POLYPEPTIDES AND METHODS OF USE THEREOF
IL296209A (en) 2020-05-12 2022-11-01 Cue Biopharma Inc Multimeric t-cell modulatory polypeptides and methods of using them
JP2023541366A (ja) 2020-09-09 2023-10-02 キュー バイオファーマ， インコーポレイテッド １型真性糖尿病（ｔ１ｄ）を治療するためのｍｈｃクラスｉｉ ｔ細胞調節多量体ポリペプチド及びその使用方法
AU2022215712A1 (en) * 2021-02-07 2023-09-07 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Bispecific antibody
CN117222421A (zh) * 2021-03-19 2023-12-12 Cue生物制药股份有限公司 T细胞调节多肽和其使用方法
EP4308143A4 (en) * 2021-03-19 2025-06-04 Cue Biopharma, Inc. T-cell modulatory polypeptides and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69839443D1 (de) * 1997-05-08 2008-06-19 Biomira Inc Verfahren zur gewinnung von aktivierten t-zellen und mit antigen inkubierten antigenpräsentierenden zellen
US7696306B2 (en) * 2003-07-11 2010-04-13 Board of Agents of the University of Nebraska Compositions and methods for preventing or treating cancer
SG11201408530YA (en) * 2012-08-02 2015-03-30 Hoffmann La Roche Method for producing monomeric and multimeric molecules and uses thereof
JP6652932B2 (ja) * 2014-06-18 2020-02-26 アルバート アインシュタイン カレッジ オブ メディシン ｓｙｎＴａｃポリペプチド及びその使用
AU2016303497A1 (en) * 2015-07-31 2018-03-01 Tarveda Therapeutics, Inc. Compositions and methods for immuno-oncology therapies
WO2017151940A2 (en) * 2016-03-03 2017-09-08 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
WO2017152042A2 (en) * 2016-03-04 2017-09-08 New York University Virus vectors expressing multiple epitopes of tumor associated antigens for inducing antitumor immunity
SG11201808552XA (en) * 2016-05-18 2018-10-30 Cue Biopharma Inc T-cell modulatory multimeric polypeptides and methods of use thereof
CN110177564A (zh) * 2016-12-13 2019-08-27 德里尼亚公司 多价的调节t细胞调节剂
CN110325205B (zh) * 2016-12-22 2023-08-15 库尔生物制药有限公司 T细胞调节性多聚体多肽及其使用方法
KR20190123328A (ko) * 2017-03-09 2019-10-31 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 암 백신
KR20240005989A (ko) * 2017-03-15 2024-01-12 큐 바이오파마, 인크. 면역 반응을 조절하는 방법
EP3446702A1 (en) * 2017-08-23 2019-02-27 Medizinische Hochschule Hannover Synthetic vaccine
WO2019051127A1 (en) * 2017-09-07 2019-03-14 Cue Biopharma, Inc. MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF
MX2020002596A (es) * 2017-09-07 2020-07-20 Cue Biopharma Inc Polipeptidos moduladores de linfocitos t multimericos y metodos de uso de estos.

Similar Documents

Publication Publication Date Title
JP2022515330A5 (enExample)
JP2022548472A5 (enExample)
IL272085B2 (en) Multimeric t-cell modulatory polypeptides and methods of use thereof
JP2021500855A5 (enExample)
JP2019512222A5 (enExample)
IL308851B1 (en) T cell modulatory multimeric polypeptides and methods of using them
JP2022534846A5 (enExample)
JP2023059873A5 (enExample)
CN110785435B (zh) 与il-12和il-18的基于il-15的融合物
JP2024512470A5 (enExample)
JP2023527049A5 (enExample)
JP2017519491A5 (enExample)
JP2018525006A5 (enExample)
JP2020533273A5 (enExample)
US10865243B2 (en) Chimeric antigen receptor and its use
JP2022515331A5 (enExample)
JP2021137024A5 (enExample)
JP2022109953A5 (enExample)
JP2020514375A5 (enExample)
CA2764649C (en) Multimeric polypeptides of hla-g including alpha1-alpha3 monomers and pharmaceutical uses thereof
JP2022522405A5 (enExample)
JP2023526723A5 (enExample)
JP2019501647A5 (enExample)
CA2318482A1 (en) Il-18 receptors
CA2407680A1 (en) Dendritic cell co-stimulator molecules